KAMAL KABAKIBOU: Open Payments
NPI 1356427850 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,507 in 62 payments from 21 companies in 2025. Trend: 2023 $2,159 · 2024 $1,740 · 2025 $1,507
Food & beverage: $1,387Education: $120
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $263 |
| Abbott Laboratories | 3 | $139 |
| Globus Medical, Inc. | 2 | $115 |
| UCB, Inc. | 4 | $109 |
| E.R. Squibb & Sons, L.L.C. | 4 | $90 |
| Lundbeck LLC | 3 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $84 |
| ANI Pharmaceuticals, Inc. | 3 | $81 |
| Amgen Inc. | 3 | $76 |
| Axsome Therapeutics, Inc. | 3 | $74 |
Products named: PROCLAIM, QULIPTA, Senza, Bimzelx, ORENCIA, VYEPTI, RELISTOR, PURIFIED CORTROPHIN GEL.
Industry payments across GA — which companies pay providers there.
